Today's Trend
Marsh & McLennan Companies, Inc. (NYSE: MRSH) received a mixed set of earnings-estimate revisions from Zacks Research on August 11. The changes suggest modestly improved longer-term earnings expectations, but near-term reductions may be limiting investor enthusiasm and contributing to weaker trading.
- Zacks raised its FY2026 EPS forecast to $10.40 from $10.33, FY2027 EPS to $11.23 from $11.19, and FY2028 EPS to $12.13 from $11.93. The firm also increased estimates for Q4 2026, Q1 and Q2 2027, and Q1 and Q2 2028, indicating improved expectations for Marsh & McLennan’s longer-term earnings growth.
- Zacks’ FY2026 forecast of $10.40 remains slightly below the broader analyst consensus of $10.43, so the revisions represent only a modest improvement relative to current expectations.
- Zacks lowered its Q3 2026 EPS estimate to $1.95 from $1.97, Q3 2027 to $2.21 from $2.24, and Q4 2027 to $2.52 from $2.61. These cuts point to some pressure in upcoming or intermediate reporting periods and may weigh on the stock despite the higher full-year forecasts.
Overall, the revisions are slightly favorable over the long term but mixed across individual quarters. With MRSH already trading at a valuation of roughly 23 times earnings, investors may require stronger near-term estimate momentum for the stock to move higher.